Vertex aims for broad kidney disease label ahead of key readout next year

Vertex Pharmaceuticals reported that an experimental kidney disease drug called inaxaplin improved measures on a urine test in two different patient populations, raising optimism ahead of the company’s upcoming pivotal readout. ...